secwatch.observer — SEC 8-K summary
======================================

Issuer:     Applied Molecular Transport Inc. (—)
CIK:        0001801777
Form:       8-K
Filed at:   2023-12-27T23:59:59+00:00
Accession:  0001437749-23-035381
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied Molecular Transport completes merger with Cyclo Therapeutics; AMTI becomes wholly owned subsidiary
--------------------------------------------------------------------------------

- Each AMTI share converted into 0.1331 shares of Cyclo common stock at merger effective December 27, 2023.
- AMTI requested Nasdaq to suspend trading and delist AMTI common stock; will file Form 15 to deregister.
- All AMTI directors and officers ceased; former AMTI director Shawn Cross appointed to Cyclo board.
- AMTI's charter and bylaws amended and restated per the Merger Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801777/000143774923035381/0001437749-23-035381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801777/000143774923035381/amti20231222_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-035381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer